Involvement of FFA Metabolism and Insulin Resistance in Cardiac Death

NCT01068080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 155

Last updated 2010-02-12

No results posted yet for this study

Summary

The investigators evaluated predictive values of myocardial fatty acid metabolism and insulin resistance for cardiac death of hemodialysis patients with normal coronary arteries.

Conditions

Sponsors & Collaborators

  • Toujinkai Hospital

    lead OTHER

Principal Investigators

  • Toshihiko Ono, MD · Toujinkai Group

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Completion
2004-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01068080 on ClinicalTrials.gov